January 29 ‑ Optune Lua™ Tumor Therapy System
-
Estimated Delivery:Oct 13 - Oct 17
-
Free Shipping & Returns: On all orders over $75
Optune Lua™ (NovoTTF‑100L) Tumor Therapy System
Model: NovoTTF‑100LManufacture Date: Jul 01, 2019Condition: GoodPrice: USD 15,000 (including electrode patches)
Basic Configuration
Optune Lua is a TTFields system for treating thoracic tumors such as malignant pleural mesothelioma.
Technical Specifications of NovoTTF‑100L TTFields System
‑ Device Name: Optune Lua TTFields System (Formerly NovoTTF‑100L)‑ Technology: Tumor Treating Fields (TTFields)‑ Main Components: Portable field generator, transducer arrays, batteries, power supply, charger, carrying case‑ Operating Frequency: ~150 kHz (preset)‑ Therapy Mode: Non‑invasive electric field therapy‑ Power Source: Battery‑operated or mains‑powered‑ Wearable: Yes (approx. 1.2 kg / 2.7 lbs with battery)‑ Recommended Daily Usage: ≥12 hours per day (clinically typically ≥18 hours per day)‑ Indications: Malignant pleural mesothelioma and other specified tumors (subject to local regulatory approval)
Key Features
‑ Non‑invasive TTFields cancer therapy‑ Portable wearable design for daily use‑ Low systemic side‑effects‑ Personalized placement of transducer arrays‑ Compatible with standard cancer treatment regimens‑ Preset safety‑controlled operating parameters
